Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-10-2020 | Imipenem | Brief Report

First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Authors: Zain Malik, Punit J. Shah, Farheen Tariq

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2020

Abstract

Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was successfully treated with a 6-week course of imipenem and trimethoprim-sulfamethoxazole.

World Health Organization (2017) Guidelines for drinking-water quality: fourth edition incorporating the first addendum. World Health Organization, Geneva

Safaei S, Fatahi-Bafghi M, Pouresmaeil O (2018) Role of Tsukamurella species in human infections: first literature review. New Microbes New Infect 22:6–12. https://doi.org/10.1016/j.nmni.2017.10.002CrossRefPubMed

Schwartz MA, Tabet SR, Collier AC, Wallis CK, Carlson LC, Nguyen TT, Kattar MM, Coyle MB (2002) Central venous catheter-related bacteremia due to Tsukamurella species in the immunocompromised host: a case series and review of the literature. Clin Infect Dis 35:e72–e77. https://doi.org/10.1086/342561CrossRefPubMed

Shim HE, Sung H, Baek SM et al (2009) A case of catheter-related bacteremia of Tsukamurella pulmonis. Korean J Lab Med 29(1):41–47. https://doi.org/10.3343/kjlm.2009.29.1.41CrossRefPubMed

Suzuki J, Sasahara T, Toshima M et al (2017) Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review. BMC Infect Dis 17(1):677. https://doi.org/10.1186/s12879-017-2796-8CrossRefPubMedPubMedCentral

Takebe I, Sawabe E, Ohkusu K et al (2014) Catheter-related bloodstream infection by Tsukamurella inchonensis in an immunocompromised patient. J Clin Microbiol 52(6):2251–2253. https://doi.org/10.1128/JCM.00421-14CrossRefPubMedPubMedCentral

Lai KK (1993) A cancer patient with central venous catheter-related sepsis caused by Tsukamurella paurometabolum (Gordona aurantiaca). Clin Infect Dis 17(2):285–287. https://doi.org/10.1093/clinids/17.2.285-aCrossRefPubMed

Long SS, Pickering LK, Prober CG (2012) Principles and practice of pediatric infectious disease. Elsevier/Saunders, Amsterdam

Bharadwaj R, Swaminathan S, Salimnia H, Fairfax M, Frey A, Chandrasekar PH (2012) Clinical impact of the use of 16S rRNA sequencing method for the identification of “difficult-to-identify” bacteria in immunocompromised hosts. Transpl Infect Dis 14:206–212. https://doi.org/10.1111/j.1399-3062.2011.00687.xCrossRefPubMed

10.

Maertens J, Wattiau P, Verhaegen J, Boogaerts M, Verbist L, Wauters G (1998) Catheter-related bacteremia due to Tsukamurella pulmonis. Clin Microbiol Infect 4:51–53. https://doi.org/10.1111/j.1469-0691.1998.tb00336.xCrossRefPubMed

11.

Karunakaran R, Halim HA, Ng KP et al (2011) Tsukamurella tyrosinosolvens intravascular catheter-related bacteremia in a haematology patient: a case report. Eur Rev Med Pharmacol Sci 15(11):1343–1346PubMed

12.

Shapiro CL, Haft RF, Gantz NM, Doern GV, Christenson JC, O’Brien R et al (1992) Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer. Clin Infect Dis 14(1):200–203CrossRef

Title: First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy
Authors: Zain Malik
Punit J. Shah
Farheen Tariq
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Imipenem
Endocarditis
Cytostatic Therapy
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03917-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2020

Analysis of C. difficile infection–related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

Mechanism of Candida pathogenesis: revisiting the vital drivers

Implementation of the eazyplex® CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital

Rapid identification of uropathogens by combining Alfred 60 system with matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry technology

Evaluation of ultra-rapid susceptibility testing of ceftolozane-tazobactam by a flow cytometry assay directly from positive blood cultures

Nosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage